Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2011; 17(9): 1160-1166
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1160
Figure 1
Figure 1 Study design (the percentages refer to recruited patients). PPI: Proton pump inhibitor. Pts: Patients.
Figure 2
Figure 2 Distribution of heartburn intensity at 3 mo (top panels) and 6 mo (bottom panels) therapy in erosive esophagitis (left panels) and non erosive reflux disease patiens (right panels). EE: Erosive esophagitis; NERD: Non erosive reflux disease.
Figure 3
Figure 3 Additional symptoms assessed at baseline and at study end by QUestionario Italiano Diagnostico questionnaire (data are presented for the 398 patients completing the study). Baseline vs study end, for all symptoms, P < 0.001.